• Encompass Health priced USD 500 million of 5.875% senior notes due 2034 at 100% of par in a private offering.
• Net proceeds, together with cash on hand, earmarked to redeem USD 400 million of 4.5% senior notes due 2028 at par.
• Remaining funds to repay USD 100 million under senior secured revolving credit facility, cover related fees and expenses.
• Offering expected to close May 29.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Encompass Health Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000785161-26-000156), on May 15, 2026, and is solely responsible for the information contained therein.